EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY 4.0

Headaches and facial pain attributed to SARS‐CoV‐2 infection and vaccination: a systematic review

Dimos-Dimtirios D Mitsikostas iD, Edoardo Caronna iD, Marina De Tommaso iD, Christina I Deligianni iD, Esme Ekizoglu iD, Hayrunnisa Bolay iD, Carl H Göbel, Espen Saxhaug Kristoffersen iD, Christian Lampl iD, Elena Moro iD, Patricia Pozo-Rosich iD, Johann Sellner iD und 2 weitere

European Journal of Neurology · 2024

DOI: 10.1111/ene.16251 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift European Journal of Neurology, 2024. Verfasst von Dimos-Dimtirios D Mitsikostas und 13 weiteren Autor:innen. Beteiligte Einrichtung: Neurology Department, Aeginition Hospital, Medical School, National & Kapodistrian University of Athens, Athens, Greece. Hauptthemen laut MEDLINE: COVID-19, COVID-19 Vaccines, Facial Pain, Headache. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 95 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and purpose The aim was to provide insights to the characteristics of headache in the context of COVID‐19 on behalf of the Headache Scientific Panel and the Neuro‐COVID‐19 Task Force of the European Academy of Neurology (EAN) and the European Headache Federation (EHF).

Methods

Following the Delphi method the Task Force identified six relevant questions and then conducted a systematic literature review to provide evidence‐based answers and suggest specific diagnostic criteria.

Results

No data for facial pain were identified in the literature search. (1) Headache incidence during acute COVID‐19 varies considerably, with higher prevalence rates in prospective compared to retrospective studies (28.9%–74.6% vs. 6.5%–34.0%). (2) Acute COVID‐19 headache is usually bilateral or holocranial and often moderate to severe with throbbing pain quality lasting 2–14 days after first signs of COVID‐19; photo‐phonophobia, nausea, anosmia and ageusia are common associated features; persistent headache shares similar clinical characteristics. (3) Acute COVID‐19 headache is presumably caused by immune‐mediated mechanisms that activate the trigeminovascular system. (4) Headache occurs in 13.3%–76.9% following SARS‐CoV‐2 vaccination and occurs more often amongst women with a pre‐existing primary headache; the risk of developing headache is higher with the adenoviral‐vector‐type vaccines than with other preparations. (5) Headache related to SARS‐CoV‐2 vaccination is mostly bilateral, and throbbing, pressing, jolting or stabbing. (6) No studies have been conducted investigating the underlying mechanism of headache attributed to SARS‐CoV‐2 vaccines.

Conclusion

The results of this joint EAN/EHF initiative provide a framework for a better understanding of headache in the context of SARS‐CoV‐2 infection and vaccination.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19COVID-19 VaccinesFacial PainHeadacheHumansSARS-CoV-2Vaccination

Stichwörter der Autor:innen

chronic daily headacheheadacheneurological disorders

Substanzen

COVID-19 Vaccines

Autor:innen und Institutionen

  • Neurology Department, Aeginition Hospital, Medical School, National & Kapodistrian University of Athens, Athens, Greece.
  • Headache Unit, Neurology Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
  • Headache and Neurological Pain Research Group, Department of Medicine, Vall d'Hebron Research Institute, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Neurophysiopathology Unit, DiBrain Department, Aldo Moro University, Bari, Italy.
  • Athens Naval Hospital, Athens, Greece.
  • Department of Neurology, Faculty of Medicine, Istanbul University, Istanbul, Istanbul, Turkey.

ORCID-Profile: Dimos-Dimtirios D Mitsikostas, Edoardo Caronna, Marina De Tommaso, Christina I Deligianni, Esme Ekizoglu, Hayrunnisa Bolay, Espen Saxhaug Kristoffersen, Christian Lampl, Elena Moro, Patricia Pozo-Rosich, Johann Sellner, Gisela Terwindt, Pablo Irimia-Sieira

Zitieren

APA

Mitsikostas, D. D., Caronna, E., De Tommaso, M., Deligianni, C. I., Ekizoglu, E., Bolay, H., Göbel, C. H., Kristoffersen, E. S., Lampl, C., Moro, E., Pozo-Rosich, P., Sellner, J., Terwindt, G., & Irimia-Sieira, P. (2024). Headaches and facial pain attributed to SARS‐CoV‐2 infection and vaccination: a systematic review. European Journal of Neurology. https://doi.org/10.1111/ene.16251

Vancouver

Mitsikostas DD, Caronna E, De Tommaso M, Deligianni CI, Ekizoglu E, Bolay H, et al. Headaches and facial pain attributed to SARS‐CoV‐2 infection and vaccination: a systematic review. European Journal of Neurology. 2024. doi:10.1111/ene.16251

BibTeX
@article{Mitsikostas2024,
  author = {Mitsikostas, Dimos-Dimtirios D and Caronna, Edoardo and De Tommaso, Marina and Deligianni, Christina I and Ekizoglu, Esme and Bolay, Hayrunnisa and Göbel, Carl H and Kristoffersen, Espen Saxhaug and Lampl, Christian and Moro, Elena and Pozo-Rosich, Patricia and Sellner, Johann and Terwindt, Gisela and Irimia-Sieira, Pablo},
  title = {Headaches and facial pain attributed to SARS‐CoV‐2 infection and vaccination: a systematic review},
  journal = {European Journal of Neurology},
  year = {2024},
  doi = {10.1111/ene.16251}
}
Kostenlos starten →